The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
Retatrutide, tested at 9 mg and 12 mg doses alongside diet and exercise, met all primary and key secondary endpoints
Golcadomide, a CELMoD agent, continued to deliver deep and durable responses in aggressive B-cell and follicular lymphomas
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
The launch of the study was on the occasion of the International Day of Persons with Disabilities
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
Subscribe To Our Newsletter & Stay Updated
